Biological Dynamics - About the company
Biological Dynamics is a series C company based in San Diego (United States), founded in 2010 by Raj Krishnan. It operates as a Provider of molecular diagnostics plaform. Biological Dynamics has raised $67.6M in funding from investors like Heritage Group, Alexandria and Qualcomm. The company has 110 active competitors, including 44 funded and 14 that have exited. Its top competitors include companies like Anteo Tech, Fluidic Analytics and Molcure.
Company Details
Biological Dynamics has developed a proprietary lab-on-chip (LOC) platform (ACE) for direct and selective isolation of nanoparticles from physiological solutions. Its platform uses a direct-to-analyte approach for nanoparticles isolation (no isolation or sample prep). The company is developing minimally invasive diagnostic assays that detect cell-free dsDNA, exosomes, and other cellular debris.
- Website
- biologicaldynamics.com
- Phone Number
- +1 **********
- Registered Address
- San Diego, California
Key Metrics
Founded Year
2010
Location
San Diego, United States
Stage
Series C
Total Funding
$67.6M in 10 rounds
Latest Funding Round
Investors
Ranked
1st among 110 active competitors
Employee Count
54 as on Dec 31, 2022
Similar Companies
Legal entities associated with Biological Dynamics
Biological Dynamics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Biological Dynamics, Inc. CIN: 262079601 , United States, Active | Dec 31, 2009 | - | 84 (As on Dec 31, 2023) | - |
Sign up to download Biological Dynamics' company profile
Biological Dynamics's funding and investors
Biological Dynamics has raised a total funding of $67.6M over 10 rounds. Its first funding round was on 2011. Its latest funding round was a Series C round on Nov 06, 2020 for $*****. 3 investors participated in its latest round. Biological Dynamics has 8 institutional investors.
Here is the list of recent funding rounds of Biological Dynamics:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 06, 2020 | 7499377 | Series C | 8067396 | 2371492 | 2554316 | 8900474 |
Feb 20, 2020 | 5793329 | Grant (prize money) | 1676181 | 5612890 | 1051775 | |
Oct 31, 2019 | 4430765 | Series C | 3974282 | 7039592 | 5973018 | 5220530 |
View details of Biological Dynamics's funding rounds and investors
Biological Dynamics' founders and board of directors
Founder? Claim ProfileThe founders of Biological Dynamics is Raj Krishnan.
Here are the details of Biological Dynamics' key team members:
- Raj Krishnan: Former Founder & CEO of Biological Dynamics. Contact Info: 1 email address
View details of Biological Dynamics's Founder profiles and Board Members
Biological Dynamics' employee count trend
Biological Dynamics has 54 employees as of Dec 22. The total employee count is 8.0% more than what it was in Dec 21. Here is Biological Dynamics's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Biological Dynamics's Competitors and alternates
Top competitors of Biological Dynamics include Anteo Tech, Fluidic Analytics and Molcure. Here is the list of Top 10 competitors of Biological Dynamics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Biological Dynamics 2010, San Diego (United States), Series C | Provider of molecular diagnostics plaform | $67.6M | 58/100 | |
2nd | Anteo Tech 1995, Eight Mile Plains (Australia), Public | Supplier of advanced material solutions in the battery materials and life sciences markets | - | 56/100 | |
3rd | Fluidic Analytics 2013, Cambridge (United Kingdom), Series C | Develops microfluidic-based tools for protein characterization | $40.5M | 55/100 | |
4th | Provider of AI-based platform for drug discovery and design | $11.7M | 53/100 | ||
5th | Miroculus 2014, San Francisco (United States), Acquired | Developer of MicroRNA profiling platform to detect genes in the sample | $48.4M | 50/100 | |
6th | Oxford Immunotec 2002, Abingdon (United Kingdom), Acquired | Commercial-stage diagnostics company using immune markers to diagnose disease | $94M | 50/100 | |
7th | Nanosphere 1999, Northbrook (United States), Acquired | Provider of diagnostic tests for personalized medicine | $97.8M | 48/100 | |
8th | miDiagnostics 2015, Leuven (Belgium), Series D | Provider of disposable chips for rapid diagnostics | $113M | 45/100 | |
9th | Precision Nanosystems 2010, Vancouver (Canada), Acquired | Manufactures instruments, kits, and reagents for nanomedicine development | $25.4M | 44/100 | |
10th | IDEX Health & Science 2002, Rohnert Park (United States), Unfunded | Optofluidic and optical solutions for life science and health industries | - | - | 44/100 |
Looking for more details on Biological Dynamics's competitors? Click here to see the top ones
Biological Dynamics's Investments and acquisitions
Biological Dynamics has made no investments or acquisitions yet.
Reports related to Biological Dynamics
Here is the latest report on Biological Dynamics's sector:
News related to Biological Dynamics
•
Biological Dynamics Announces Expanding Adoption of ExoVerita™ Pro Under Early Access ProgramBusiness Wire•Apr 02, 2024•Biological Dynamics
•
Leading Academic Medical Centers Join Biological Dynamics’ ExoLuminate™ Study, Expanding Enrollment for Early Pancreatic Cancer DetectionBusiness Wire•Dec 05, 2023•Biological Dynamics
•
Biological Dynamics Announces Early Access Program to Its ExoVerita™ Pro PlatformBusiness Wire•Nov 08, 2023•Biological Dynamics
•
New Study Using Biological Dynamics’ ExoVerita Platform Validates Exosome Detection of Early-Stage Pancreatic Ductal Adenocarcinoma (PDAC)Business Wire•Oct 19, 2023•Biological Dynamics
•
Biological Dynamics to Share Data at 2023 Early Detection of Cancer Conference in London, Highlighting Value of Exosome-based Liquid Biopsy Assay in Detecting Pancreatic CystsBusiness Wire•Oct 05, 2023•Biological Dynamics
•
Biological Dynamics and The Pancreatic Cancer Early Detection Consortium (PRECEDE) Collaborate to Improve Surveillance of Early Pancreatic CancerBusiness Wire•Sep 06, 2023•Biological Dynamics, Precedestudy
•
Biological Dynamics to Present Data at AACR Highlighting ExoVerita Platform-Enabled Earlier Detection of Pancreatic and Lung CancersBusiness Wire•Apr 14, 2023•Biological Dynamics
•
Biological Dynamics Appoints Zach Miller to Board of DirectorsBusiness Wire•Mar 07, 2023•Biological Dynamics
•
Biological Dynamics, OHSU Partner to Validate Pancreatic Cancer Early Detection TestGenomeWeb•Mar 02, 2023•Biological Dynamics, Oregon Health & Science University
•
Biological Dynamics, Perlmutter Cancer Center at NYU Langone Health collaborate on pancreatic cancer researchTullahoma News•Jan 31, 2023•Biological Dynamics, NYU Langone
Are you a Founder ?
FAQs about Biological Dynamics
Explore our recently published companies
- BIA Home Care Service - Pittsburgh based, 2021 founded, Unfunded company
- JK Auto & Truck Repair - Marlton based, Unfunded company
- Lippert - Elkhart based, 1956 founded, Unfunded company
- AMZ Tech Solutions - Cedar Rapids based, Unfunded company
- ItsGuru - Houston based, 2006 founded, Unfunded company
- Anh Totti Nguyen - Unfunded company